We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Atricure Inc (ATRC) USD0.001

Sell:$30.52 Buy:$30.60 Change: $0.005 (0.02%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$30.52
Buy:$30.60
Change: $0.005 (0.02%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$30.52
Buy:$30.60
Change: $0.005 (0.02%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Contact details

Address:
7555 Innovation Way
MASON
45040
United States
Telephone:
+1 (513) 7554100
Website:
https://www.atricure.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ATRC
ISIN:
US04963C2098
Market cap:
$1.49 billion
Shares in issue:
48.75 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Carrel
    President, Chief Executive Officer, Director
  • Angela Wirick
    Chief Financial Officer
  • Douglas Seith
    Chief Operating Officer
  • Deborah Yount
    Chief Human Resource Officer
  • Salvatore Privitera
    Chief Technical Officer
  • Justin Noznesky
    Chief Marketing and Strategy Officer
  • Vinayak Doraiswamy
    Chief Scientific Officer
  • Karl Dahlquist
    Chief Legal Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.